IARC group 1

From Wikipedia, the free encyclopedia
(Redirected from IARC Group 1)
Jump to navigation Jump to search

IARC group 1 Carcinogens are substances, chemical mixtures, and exposure circumstances which have been classified as carcinogenic to humans by the International Agency for Research on Cancer (IARC).[1] This category is used when there is sufficient evidence of carcinogenicity in humans. Exceptionally, an agent (chemical mixture) may be placed in this category when evidence of carcinogenicity in humans is less than sufficient, but when there is sufficient evidence of carcinogenicity in experimental animals and strong evidence in exposed humans that the agent (mixture) acts through a relevant mechanism of carcinogenicity.

This list focuses on the hazard linked to the agents. This means that while carcinogens are capable of causing cancer, it does not take their risk into account, which is the probability of causing a cancer, given the level of exposure to this carcinogen.[2] The list is up to date as of January 2024.[3]

Agents

[edit | edit source]

Infectious conditions

[edit | edit source]

Viruses

[edit | edit source]

[4]

Bacterium

[edit | edit source]

Worms

[edit | edit source]

Chemical substances

[edit | edit source]

Radiations and physical agents thereof

[edit | edit source]

Complex mixtures/agents

[edit | edit source]

Exposure circumstances

[edit | edit source]

See also

[edit | edit source]

Notes

[edit | edit source]
  1. ^ This evaluation applies to the group of compounds as a whole and not necessarily to all individual compounds within the group.
  2. ^ a b c d Evaluated as a group.
  3. ^ There is also conclusive evidence that this agent (tamoxifen) reduces the risk of contralateral breast cancer.
  4. ^ a b Specific radionuclides for which there is sufficient evidence for carcinogenicity to humans are also listed individually as Group 1 agents.
  5. ^ There is also convincing evidence in humans that these agents confer a protective effect against cancer in the endometrium and ovary.
  6. ^ Overall evaluation upgraded to Group 1 with strong supporting evidence from other relevant data.

References

[edit | edit source]
  1. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  2. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  3. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  4. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  5. ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  6. ^ a b c Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  7. ^ a b c Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  8. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  9. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
[edit | edit source]